ADRC News

Barbara Fischer, PsyD, and Carey Gleason, PhD, MS, recently published research findings about a blood biomarker and a method of testing cognitive processes that could hold promise for identifying middle-aged Black people who are at risk for later developing Alzheimer’s disease.

Lauren W. Yowelunh McLester-Davis, PhD, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy.

Cynthia Carlsson, MD, MS, is leading a research team at UW–Madison investigating a drug that could one day prevent Alzheimer’s disease.

The annual awards acknowledge and honor women of color among UW–Madison’s faculty, staff, students and in the greater Madison community whose advocacy, activism, or scholarship has fostered social justice and organizational change.

Kimberly Mueller, PhD, CCC-SLP, was recently appointed to associate professor with tenure in the Department of Communication Sciences and Disorders at the University of Wisconsin–Madison.

Brain assessments of World War II, Korean and Vietnam War-era veterans uncover disease biomarkers.

Nathaniel Chin, MD, discusses the impact of new Alzheimer’s treatments in memory care in a commentary published in the Journal of the American Geriatrics Society.

Researchers are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.

The past decade of National Institutes of Health (NIH)-funded Alzheimer’s disease and related dementias research yielded multiple scientific advances. Learn more via the 2023 NIH dementia research scientific progress report.

Sterling Johnson, PhD, was recently recognized by the University of Wisconsin Department of Medicine (DOM) as an Outstanding Senior Faculty Researcher.